Discovery of mevalonate and UBIAD1 inhibitors as novel drugs targeting melanoma skin cancer

Project Information

MELASTOP

Grant agreement ID: 963865

DOI

10.3030/963865

Project closed

EC signature date 14 December 2020

Start date 1 July 2021

End date 30 June 2024

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

UNIVERSITA DEGLI STUDI DI PADOVA
Italy

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

UBIAD1 and CoQ10 protect melanoma cells from lipid peroxidation-mediated cell death

Author(s): Liaisan Arslanbaeva Giovanni Tosi,Marco Ravazzolo,Manuela Simonato, Francesco A. Tucci, Salvatore Pece, Paola Cogo and Massimo M. Santoro
Published in: Redox Biology, 2022, ISSN 2213-2317
Publisher: Elsevier BV
DOI: 10.1016/j.redox.2022.102272

Exploiting the metabolic vulnerability of circulating tumour cells

Author(s): Munise Merteroglu, Massimo M Santoro
Published in: Trends in Cancer, 2024, ISSN 2405-8033
Publisher: Elsevier
DOI: 10.1016/j.trecan.2024.03.004